08045804815

TABNCAP HEALTHCARE
GST : 24AAMFT3098D1Z1

Our Products

Ophthalmic Diagnostic Test Strips

Intraocular Lenses

Contact Lenses

Ophthalmic Solutions and Viscoelastics

Vitreoretinal Products

Ophthalmic Machine

Hyaluronic Acid Gel for Dremel

Hyaluronic Acid Gel for Dremel

Absorbable Hemostatic Gelatin Sponge And Powder

Natural Colors Contact Lens

Home Care Products

Skin Care Products

C3F8 Microgas - Intraocular Gas

C3F8 Microgas - Intraocular Gas Specification

Features
Long-acting, high purity, non-toxic, non-explosive

Storage Instructions
Store below 25C, keep away from direct sunlight

Function
Vitreous replacement/tamponade in retinal detachment

Shelf Life
24 months from the date of manufacturing

Usage Type
Medical, Surgical

Instruments Type
Intraocular gas for ophthalmic microsurgery

Equipment Type
Intraocular Gas

Material
Perfluoropropane (C3F8)

Condition
New

Technology
Medical gas technology for retinal surgery

Portable
Yes

Wall Mounted
No

Real-Time Operation
Yes

Operating Type
Disposable single-use

Use
For Vitro Retinal Surgery

Dimension (L*W*H)
5 ml or 10 ml vial

Weight
Approx. 20 g (varies as per vial size)

Color
Colorless gas

Batch/Lot Number
Printed on each vial

Concentration
99.9% pure C3F8

Pyrogen Status
Pyrogen free

Manufacturer's Certification
Complies with international quality standards for ophthalmic gases

Intended Application
Retinal detachment repair, macular hole surgery, vitreoretinal procedures

Latex Free
Yes

Contraindications
Do not use in the presence of intraocular silicone oil

Administration Route
Injected intraocularly by ophthalmic surgeon

Packaging
Sterile sealed vial packed in medical grade box

Explosion Risk
Not explosive under prescribed conditions

C3F8 Microgas - Intraocular Gas Trade Information

Minimum Order Quantity
1 , , Unit

FOB Port
Ahmedabad

Payment Terms
Letter of Credit (L/C), Letter of Credit at Sight (Sight L/C), Telegraphic Transfer (T/T), Cash in Advance (CID), Cash Advance (CA)

Supply Ability
50 Units Per Month

Delivery Time
3-5 Days

Sample Available
Yes

Sample Policy
Sample costs shipping and taxes has to be paid by the buyer

Packaging Details
One Kit for C3F8

Main Export Market(s)
Western Europe, South America, Eastern Europe, Middle East, Central America, Asia, Africa

Main Domestic Market
All India

Certifications
COA, CE certificate can be available

About C3F8 Microgas - Intraocular Gas

PERFLUOROPROPANE (C3F8) is an expanding fluorinated hydrocarbon gas used during vitreoretinal surgery to provide prolonged internal retinal tamponade. C3F8 has been demonstrated to increase the rate of retinal reattachment in the management of rhegmatogenous retinal detachment (RRD) complicated by proliferative vitreoretinopathy (PVR). The primary complication of C3F8 use is intraocular-pressure (IOP) elevation that may lead to glaucomatous nerve damage. To prevent this potentially sight-threatening event, surgeons attempt to achieve a nonexpanding concentration of 12 to 20% C3F8 by either passing a large-volume infusion of the nonexpanding concentration through the air-filled vitreous cavity (fixed-concentration (FC) method) or by injecting a finite volume of 100% C3F8 that, when mixed with the volume of air present in the vitreous, produces a nonexpanding concentration (fixed-volume (FV) method).

C3F8 to be used for vitro retinal detachment treatment for 4-6 weeks.

The Expiry of the product is indicative only. The actual product shall be within expiry of the total shelf life of 5years.

Purpose-Built for Retinal Surgeries

C3F8 Microgas delivers targeted support in ophthalmic microsurgery, especially for retinal detachment repair, macular hole procedures, and other complex vitreoretinal interventions. Its high purity and reliable performance make it an essential tool for trained ophthalmic surgeons, ensuring optimal outcomes for delicate intraocular procedures.

Safe and Certified Performance

Manufactured in Italy, C3F8 Microgas is pyrogen free, latex free, and non-explosive under prescribed conditions. The product complies with international quality benchmarks for medical gases, offering peace of mind to both surgeons and patients. Every sterile vial is batch-marked, ensuring traceability and manufacturing excellence.

Convenient Sterile Packaging

Each vial of C3F8 Microgas is securely packed in a medical-grade box to maintain sterility until use. The compact and portable vials are available in two practical sizes (5 ml and 10 ml), facilitating ease of handling in the operating room. Proper storage below 25C and away from direct sunlight is recommended to maintain efficacy.

FAQ's of C3F8 Microgas - Intraocular Gas:

Q: How is C3F8 Microgas administered during vitreoretinal surgery?

A: C3F8 Microgas is injected directly into the eye by a qualified ophthalmic surgeon during vitreoretinal procedures. The gas serves as a tamponade to support the retina's reattachment and promote healing.

Q: What should I know about the intended application of C3F8 Microgas?

A: This intraocular gas is primarily used for retinal detachment repair, macular hole surgery, and various other vitreoretinal procedures, providing structural support as a replacement for natural vitreous humor.

Q: When should C3F8 Microgas not be used?

A: C3F8 Microgas should not be used in cases where intraocular silicone oil is present, as this is a contraindicated condition and may compromise the effectiveness and safety of the procedure.

Q: Where can I find the batch or lot number for C3F8 Microgas?

A: The batch or lot number is clearly printed on every sterile vial, allowing for easy identification and traceability throughout the product's shelf life.

Q: What is the recommended storage condition for C3F8 Microgas vials?

A: Store the vials below 25C and keep them away from direct sunlight to preserve the quality and sterility of the gas until use.

Q: What are the benefits of using C3F8 Microgas in retinal surgery?

A: C3F8 Microgas is long-acting, high purity, non-toxic, and portable. It provides a reliable and durable tamponade effect, facilitating better post-surgical outcomes for retinal and macular problems.

Tell us about your requirement